Product Information
REPAGLINIDE 2 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0963 per EA under NDC 65862067201. Its NADAC has been published 649 times since Mar 19, 2014.
FDA first approved this application on Jan 22, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862067201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
REPAGLINIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203820FDA Approved
1/22/2014
TE Code
AB
On Market Since
1/22/2014
Pharmacological Classes
Price Statistics
The NADAC for REPAGLINIDE 2 MG TABLET has been published 649 times since Mar 19, 2014, and over the history we have for it it has declined 96.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0963 per EA |
|---|---|
| All-time high | $2.8140 (Apr 16, 2014) |
| All-time low | $0.0859 (Mar 18, 2026) |
| 52-week high | $0.1042 |
| 52-week low | $0.0859 |
| Median price | $0.1592 |
| Average price | $0.2147 |
| Largest weekly change | -84.2% (Apr 23, 2014) |
| Weeks tracked | 649 |
| Tracking since | Mar 19, 2014 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of REPAGLINIDE 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for REPAGLINIDE 2 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0963 per EA (NDC 65862067201), effective Aug 19, 2026.
How has the price of REPAGLINIDE 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for REPAGLINIDE 2 MG TABLET has declined 96.6%. It has been tracked across 649 weekly CMS publications since Mar 19, 2014.
What are the highest and lowest recorded NADAC prices for REPAGLINIDE 2 MG TABLET?
Since Mar 19, 2014, the NADAC for REPAGLINIDE 2 MG TABLET has ranged from a low of $0.0859 (Mar 18, 2026) to a high of $2.8140 (Apr 16, 2014), with a median of $0.1592 per EA.
Are there cheaper alternatives to REPAGLINIDE 2 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as REPAGLINIDE 2 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures REPAGLINIDE 2 MG TABLET?
REPAGLINIDE 2 MG TABLET (NDC 65862067201) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.